Periodic Reporting for period 1 - iMUC (Improving the Management of Unexplained Chest-pain)
Reporting period: 2014-11-01 to 2015-04-30
iMUC EndoPAT diagnostic technology is a non-invasive, robust and non-operator-dependent technology, providing an enhanced clinical tool to improve disease management.
iMUC aims to validate that scoring endothelial function using iMUC technology can help to better manage patients with chest pain and in specific those that undergo diagnostic angiography but released without intervention. In addition, iMUC aims to show and validate that adherence to and compliance with intensive life style changing is improved when progress is monitored with the novel iMUC technology.
As part of the Phase I study, Itamar Medical has established a steering committee composed of internationally renowned key opinion leaders in the field. Together with this steering committee, a detailed design of the project’s multicenter clinical trial protocol was established, including the management of the various expected risks. We have connected with over 20 medical centers worldwide that are interested to participate in the iMUC Phase II clinical study. Finally we have established the necessary relationships with a CRO as well as a bio-statistic group focused on and experienced in the cardiovascular area.
We strongly believe that it is feasible to validate the clinical benefits of the iMUC project. We also believe that the project will provide substantial potential value and growth to Itamar Medical.